Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
National Consistency In Gov't Reimbursement For Breast Prostheses, Australia
http://www.medicalnewstoday.com/articles/120767.php
The Australian Medical Association welcomed the long-awaited Federal Government rollout of a program that will help cancer survivors with the cost of new and replacement breast prostheses. AMA President, Dr Rosanna Capolingua, said the AMA had been concerned for patients and their ability to afford breast prostheses.
Breast Cancer Survival Rates Lower In Community Hospitals Than Teaching Hospitals, Study Finds
http://www.medicalnewstoday.com/articles/120745.php
<BR />Women with advanced breast cancer have lower long-term survival rates when treated in local community hospitals than at academic medical centers, according to a <A href="http://www.annalsofsurgery.
Electronic Brachytherapy A Viable Option For Early Stage Breast Cancer, According To Study Presented At ASCO Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/120719.php
Early clinical experience with the FDA cleared Axxent(R) Electronic Brachytherapy (eBx) System from Xoft demonstrates that the X-Ray-based, non-isotopic treatment is a viable option for adjuvant therapy for early-stage breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Production Of Gold Nanorods For Medical Applications, Without The Use Of Cytotoxic Additives
http://www.medicalnewstoday.com/articles/120825.php
Gold nanoparticles are under consideration for a number of biomedical applications, such as tumor treatment. A German-American research team at Carnegie Mellon University in Pittsburgh, Hunter College in New York, and the RWTH Aachen has now developed a new method for the production of nanoscopic gold rods.
Chemotherapy-Stimulated Tumor Recovery Impeded By Anti-Angiogenic Drugs
http://www.medicalnewstoday.com/articles/120819.php
Scientists have gained new insight into a mechanism whereby chemotherapy may actually assist the rapid regrowth of tumors after treatment. The research, published by Cell Press in the September issue of the journal <i>Cancer Cell</i>, also helps to explain why a combination of traditional chemotherapy with drugs that block formation of new blood vessels might impede the devastating tumor recovery that often follows cancer therapy.
Tumor Blood Vessel Cells Are Remarkably Atypical
http://www.medicalnewstoday.com/articles/120816.php
Contrary to a long-standing assumption that blood vessel cells in healthy tissues and those associated with tumors are similar, a new study unequivocally demonstrates that tumor blood vessel cells are far from normal.
Nucletron Announces Advances In Image-Guided Adaptive Brachytherapy Technology For Gynecologic Cancers Via AKH / MUW Vienna Partnership
http://www.medicalnewstoday.com/articles/120776.php
Nucletron, a knowledge-based leader in radiation oncology, and the world-class medical institution General Hospital Vienna (AKH) / Medical University of Vienna (MUW), have extended their longstanding cooperation through a multi-tiered partnership to advance image-guided adaptive brachytherapy for gynecology.
VELCADE For Multiple Myeloma Receives Front-line Approval In Canada
http://www.medicalnewstoday.com/articles/120699.php
VELCADE (bortezomib) for Injection has received Health Canada approval for front-line (first) treatment of multiple myeloma, a fatal blood cancer. As part of combination therapy, VELCADE is indicated for the treatment of patients with previously untreated multiple myeloma who are unsuitable for stem cell transplantation.
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma, Europe
http://www.medicalnewstoday.com/articles/120679.php
Janssen-Cilag / Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, announced the European Commission's approval of VELCADE in combination with melphalan and prednisone for the treatment of patients with previously untreated multiple myeloma (MM) who are not eligible for high-dose chemotherapy with bone marrow transplant.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Study Of Cervical Cancer Survivors Suggests Hormones' Role In Sexuality Is Limited
http://www.medicalnewstoday.com/articles/120678.php
Most long-term cervical cancer survivors report they have satisfying sex lives following surgical intervention, according to a recent study that challenges public perceptions of the role hormones play in sexual activity.
----------------------------------------------
** COLORECTAL CANCER News **
Recommended Follow-Up Care Lacking In Many Colorectal Cancer Survivors
http://www.medicalnewstoday.com/articles/120793.php
A new analysis reveals that fewer than half of older patients successfully treated for colorectal cancer receive the recommended screening schedule to detect any recurrence of cancer. The study, appearing in the October 15, 2008 issue of <i>CANCER</i>, a peer-reviewed journal of the American Cancer Society, indicates poor compliance to recommended monitoring of colorectal cancer survivors could affect survival.
----------------------------------------------
** LUNG CANCER News **
Lung Cancer Risk Factors For Lifelong Nonsmokers
http://www.medicalnewstoday.com/articles/120189.php
A team of international researchers have found that men who never smokehave higher death rates from lung cancer than women who have neversmoked. The new research, published in the open-access journal <i>PLoSMedicine, </i>also claims that African Americans and Asiansliving in Asia (not in the USA) who are lifelong nonsmokers have higherdeath rates from lung cancer than lifelong nonsmokers of Europeandescent.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma, Europe
http://www.medicalnewstoday.com/articles/120679.php
Janssen-Cilag / Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, announced the European Commission's approval of VELCADE in combination with melphalan and prednisone for the treatment of patients with previously untreated multiple myeloma (MM) who are not eligible for high-dose chemotherapy with bone marrow transplant.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Prostate Cancer Marker May Be Masked By Anti-Inflammatory Drugs
http://www.medicalnewstoday.com/articles/120790.php
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications.
Hybrigenics Obtains EUR 1.4 Million From OSEO To Develop Inecalcitol For The Treatment Of Prostate Cancer
http://www.medicalnewstoday.com/articles/120676.php
Hybrigenics, a bio-pharmaceutical company with a focus on research and development of new cancer treatments and specialized in protein interactions, announced today that it has obtained a EUR 1.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment